Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Renalytix AI (RNLX)
NASDAQ:RNLX
Holding RNLX?
Track your performance easily
RNLX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.18 - $2.40
Previous Close$0.21
Volume934.50K
Average Volume (3M)2.16M
Market Cap
$17.39M
Enterprise Value$21.24M
Total Cash (Recent Filing)$4.68M
Total Debt (Recent Filing)$8.54M
Price to Earnings (P/E)―
Beta1.00
Next Earnings
Nov 27, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.64
Shares Outstanding166,818,806
10 Day Avg. Volume414,611
30 Day Avg. Volume2,164,463
Standard Deviation0.49
R-Squared0.07
Alpha-0.05
Financial Highlights & Ratios
Price to Book (P/B)-4.14
Price to Sales (P/S)14.28
Price to Cash Flow (P/CF)-1.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue7.03
Enterprise Value/Gross Profit136.16
Enterprise Value/Ebitda-0.62
Forecast
1Y Price Target
$3.00Price Target Upside1348.58% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Renalytix AI News
PremiumCompany Announcements
Renalytix AI’s KidneyIntelX Gains Medicare Coverage Approval
PremiumCompany Announcements
Renalytix AI Appoints Joel R. Jung as Interim CFO
Ownership Overview
26.09% Insiders
<0.01% Mutual Funds
2.77% Other Institutional Investors
71.13% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
RNLX FAQ
What was Renalytix AI’s price range in the past 12 months?
Renalytix AI lowest stock price was $0.18 and its highest was $2.40 in the past 12 months.
What is Renalytix AI’s market cap?
Currently, no data Available
When is Renalytix AI’s upcoming earnings report date?
Renalytix AI’s upcoming earnings report date is Nov 27, 2024 which is in 6 days.
How were Renalytix AI’s earnings last quarter?
Renalytix AI released its earnings results on Oct 01, 2024. The company reported -$0.03 earnings per share for the quarter, beating the consensus estimate of -$0.04 by $0.01.
Is Renalytix AI overvalued?
According to Wall Street analysts Renalytix AI’s price is currently Undervalued.
Does Renalytix AI pay dividends?
Renalytix AI does not currently pay dividends.
What is Renalytix AI’s EPS estimate?
Renalytix AI’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Renalytix AI have?
Renalytix AI has 82,962,750 shares outstanding.
What happened to Renalytix AI’s price movement after its last earnings report?
Renalytix AI reported an EPS of -$0.03 in its last earnings report, beating expectations of -$0.04. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Renalytix AI?
Among the largest hedge funds holding Renalytix AI’s share is Gilder Gagnon Howe & Co LLC.. It holds Renalytix AI’s shares valued at N/A.
---
Renalytix AI Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$3.00 (1348.58% Upside)
$3.00 (1348.58% Upside)
Blogger Sentiment
Bullish
RNLX Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 761.1K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▲ 4.7%
Last 30 Days ▼ 11.4%
Last 30 Days ▼ 11.4%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-83.17%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-73.97%
Trailing 12-Months
Company Description
Renalytix AI
Renalytix AI PLC is a developer of artificial intelligence-enabled clinical decision support solutions for kidney disease and costly chronic medical conditions globally. The company's solutions are being designed to make significant improvements in kidney disease risk assessment, clinical care, patient stratification for drug clinical trials, and drug target discovery.
---
RNLX Earnings Call
Q3 2024
0:00 / 0:00
---
RNLX Stock 12 Month Forecast
Average Price Target
$3.00
▲(1348.58% Upside)
Technical Analysis
Best Analysts Covering RNLX
1 Year
1 Year Success Rate
1/17 ratings generated profit
1 Year Average Return
-63.45%
reiterated a buy rating 6 months ago
Copying Mark Massaro's trades and holding each position for 1 Year would result in 5.88% of your transactions generating a profit, with an average return of -63.45% per trade.
---